Janet S de Moor
Overview
Explore the profile of Janet S de Moor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
2404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tonorezos E, Devasia T, Mariotto A, Mollica M, Gallicchio L, Green P, et al.
J Natl Cancer Inst
. 2024 Jul;
116(11):1784-1790.
PMID: 39002121
Background: With aging of the population and improvements in diagnosis, treatment, and supportive care, the number of cancer survivors in the United States has increased; updated prevalence estimates are needed....
2.
Yabroff K, Shi K, Zhao J, Freedman A, Zheng Z, Nogueira L, et al.
JCO Oncol Pract
. 2024 Jan;
20(3):429-437.
PMID: 38194620
Purpose: Use of genomic testing, especially multimarker panels, is increasing in the United States. Not all tests and related treatments are covered by health insurance, which can result in substantial...
3.
Halpern M, de Moor J, Han X, Zhao J, Zheng Z, Yabroff K
Cancer Res Commun
. 2023 Sep;
3(9):1830-1839.
PMID: 37705562
Significance: Individuals diagnosed with cancer may have employment disruptions; they may also develop FHs. People with cancer who have employment changes are more likely to also have FHs. Physicians and...
4.
Williams C, Platter H, Davidoff A, Vanderpool R, Pisu M, de Moor J
Cancer Med
. 2023 May;
12(14):15424-15434.
PMID: 37218419
Background: Understanding cancer survivors' health insurance decision-making is needed to improve insurance choice, potentially resulting in reduced financial hardship. Methods: This explanatory mixed methods study assessed health insurance decision-making in...
5.
Williams C, Geiger A, Norton W, de Moor J, Senft Everson N
J Gen Intern Med
. 2022 Nov;
38(5):1200-1206.
PMID: 36451016
Background: People experiencing financial burden are underrepresented in clinical trials. Objective: Describe the prevalence of cost-related considerations influential to trial participation and their associations with person-level characteristics. Design: This cross-sectional...
6.
Williams C, Davidoff A, Halpern M, Mollica M, Castro K, Allaire B, et al.
JCO Oncol Pract
. 2022 Aug;
18(8):e1234-e1246.
PMID: 35947881
Purpose: The relationship between out-of-pocket spending and cost-related medication nonadherence among older rural- and urban-dwelling cancer survivors is not well understood. Methods: This retrospective cohort study used the Surveillance, Epidemiology,...
7.
Williams C, Rocque G, Caston N, Gallagher K, Angove R, Anderson E, et al.
PLoS One
. 2022 Aug;
17(8):e0272740.
PMID: 35930603
Uninsured or underinsured individuals with cancer are likely to experience financial hardship, including forgoing healthcare or non-healthcare needs such as food, housing, or utilities. This study evaluates the association between...
8.
de Moor J, Williams C, Blinder V
J Natl Cancer Inst Monogr
. 2022 Jul;
2022(59):79-84.
PMID: 35788373
Cancer survivors are frequently unprepared to manage the out-of-pocket (OOP) costs associated with undergoing cancer treatment and the potential for employment disruption. This commentary outlines a set of research recommendations...
9.
Freedman A, Klabunde C, Wiant K, Enewold L, Gray S, Filipski K, et al.
JCO Precis Oncol
. 2022 Feb;
2.
PMID: 35135159
Purpose: There are no nationally representative data on oncologists' use of next-generation sequencing (NGS) testing in practice. The purpose of this study was to investigate how oncologists in the United...
10.
Gardner B, Doose M, Sanchez J, Freedman A, de Moor J
JCO Precis Oncol
. 2021 Sep;
5.
PMID: 34568717
Purpose: Oncologists are increasingly using molecular profiling to inform personalized patient treatment decisions. Despite its promising utility, the integration of genomic testing into diverse clinical health care settings across geographic...